H.C. Wainwright raised the firm’s price target on Optinose (OPTN) to $18 from $5 and keeps a Buy rating on the shares based on the announced 1-for-15 reverse stock split.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.